GBIO icon

Generation Bio
GBIO

Overview Fund Activity

91 hedge funds and large institutions have $364M invested in Generation Bio in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 11 closing their positions.

Holders
91
Holders Change
+3
Holders Change %
+3.41%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
35
Reduced
24
Closed
11
Calls
$111K
Puts
$1K
Net Calls
+$110K
Net Calls Change
+$109K

Top Buyers

1
PHS
1
PFM Health Sciences
California
$18.2M
2
BlackRock
2
BlackRock
New York
$23M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.88M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$58.6M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$2.05M

Top Sellers

1
CC
1
Casdin Capital
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$14.5M
3
BI
3
BVF Inc
California
$10.3M
4
FCM
4
Farallon Capital Management
California
$19M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$79K
Name Holding Trade Value Shares
Change 		Shares
Change %
RFWA
101
RPg Family Wealth Advisory
Massachusetts
– -$5.56K -76 Closed
1 2 3 4
5